Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
depression
Biotech
NRx keeps antidepressant's blockbuster hopes alive despite flop
NRx's oral antidepressant has failed to reach statistical significance reducing depression severity in a phase 2/3 trial.
Gabrielle Masson
Apr 30, 2024 11:16am
Karuna's captains set sail in new neuropsychiatric biotech
Apr 9, 2024 8:25am
FDA clears Otsuka, Click's prescription app for depression
Apr 3, 2024 1:53pm
Brii punts HIV, depression, lung programs to potential partners
Mar 22, 2024 11:34am
Neuropsych biotech Engrail closes $157M series B
Mar 19, 2024 8:00am
FDA accepts first AI algorithm to drug development tool pilot
Jan 26, 2024 1:35pm